Rite Aid's Alzheimer's Tests Can Trigger Needless Fear, Claim Doctors

The Rite Aid Pharmacy chain’s early-detection test for Alzheimer's is being hit with a wave of criticism by doctors who say that it may result in undue fear for consumers that don't have the disease. The chain is will begin marketing the tests later this month at more than 4,000 of its stores.


And although the tests are being promoted with the help of the non-profit Alzheimer’s Foundation of America, medical professionals say that such tests should only be done in a controlled environment and under the direction of a physician.

David Knopman, Professor of Neurology at the Mayo Clinic, told Bloomberg that “teaching someone how to perform a cognitive assessment is not a trivial manner. It takes some training and background in knowing about neurology.”

Knopman warns that false positives may be a result. Other cognitive issues, such as sleep deprivation or depression may trigger responses that falsely imply Alzheimer’s or dementia. Further, Knopman indicates that a busy store environment could create difficulties and distractions for consumers while they’re being tested.

Knopman sits on the Scientific Advisory Board of Alzheimer’s Association (not to be confused with the Alzheimer’s Foundation), which does not support the Rite Aid tests.

The tests, dubbed Mini-Cog, include a set of oral and written questions that take between 5 and 10 minutes to complete. The answers that consumers give are supposed to help screen whether they may be suffering from the early stages of the neurodegenerative disease. The tests are also used to screen for dementia. The tests will be administered during a series of events to be held later in the month that are focused on senior wellness.

The Alzheimer’s Foundation of America defends its test, saying that it can raise awareness and prompt seniors to see a doctor should the test produce positive results. They further say that if even inaccurate results can serve the greater purpose of raising disease awareness, as long as consumers understand that the test results are not definitive.

Alzheimer's is a progressive form of dementia that causes problems with memory, thinking, and behavior. In its early stages, memory loss may be mild. Early symptoms may include getting confused in familiar places and taking longer than usual to complete normal daily tasks. While the disease progresses at different rates in different people, those with moderate Alzheimer's experience the fastest rate of decline.

#story_page_ below_article

Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal

Don't Sit on the Sidelines of History. Join Alternet All Access and Go Ad-Free. Support Honest Journalism.